• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[腹膜透析中真菌性腹膜炎的临床和微生物学方面]

[Clinical and microbiological aspects of fungal peritonitis in peritoneal dialysis].

作者信息

García-Agudo R, García-Martos P

机构信息

Complejo Hospitalario La Mancha-Centro, Alcázar de San Juan, Ciudad Real.

出版信息

Nefrologia. 2009;29(6):506-17. doi: 10.3265/Nefrologia.2009.29.6.5650.en.full.

DOI:10.3265/Nefrologia.2009.29.6.5650.en.full
PMID:19935994
Abstract

Peritonitis is one of the most serious complications of peritoneal dialysis. Pathogenic bacteria cause the majority of cases of peritonitis. Fungal infection is rare but it is associated with high morbidity, the inability to continue on the dialysis program and important mortality. Its incidence varies from 4% to 10% of all peritonitis episodes in children and from 1% to 23% in adults. Its clinical presentation is similar to bacterial peritonitis. Until now, predisposing factors of fungal peritonitis have not been clearly established; history of bacterial peritonitis episodes and treatment with broad-spectrum antibiotics have been often reported in the literature. Candida species were the most common pathogens and Candida albicans was the most frequent, but high prevalence of Candida parapsilosis has been observed in the last decade. Microbiological findings are essential to to determine the etiology of peritonitis. Successful management of fungal peritonitis requires antifungal therapy, the removal of peritoneal catheter and the subsequent transfer to hemodialysis. Fluconazole and amphotericin B are recommended as antifungal agents. New drugs as voriconazole and caspofungin are very effective. The aim of this systematic review has been to analyse the clinical and microbiological aspects of fungal peritonitis, as they are not well known and have changed in the last few years.

摘要

腹膜炎是腹膜透析最严重的并发症之一。大多数腹膜炎病例由病原菌引起。真菌感染较为罕见,但发病率高,无法继续进行透析治疗,且死亡率高。其发病率在儿童所有腹膜炎发作中占4%至10%,在成人中占1%至23%。其临床表现与细菌性腹膜炎相似。迄今为止,真菌性腹膜炎的易感因素尚未明确;文献中经常报道有细菌性腹膜炎发作史和使用广谱抗生素治疗的情况。念珠菌属是最常见的病原体,白色念珠菌最为常见,但在过去十年中,近平滑念珠菌的患病率较高。微生物学检查结果对于确定腹膜炎的病因至关重要。成功治疗真菌性腹膜炎需要抗真菌治疗、拔除腹膜导管并随后转为血液透析。推荐使用氟康唑和两性霉素B作为抗真菌药物。伏立康唑和卡泊芬净等新药非常有效。本系统评价的目的是分析真菌性腹膜炎的临床和微生物学方面,因为这些方面尚不为人所知,且在过去几年中有所变化。

相似文献

1
[Clinical and microbiological aspects of fungal peritonitis in peritoneal dialysis].[腹膜透析中真菌性腹膜炎的临床和微生物学方面]
Nefrologia. 2009;29(6):506-17. doi: 10.3265/Nefrologia.2009.29.6.5650.en.full.
2
Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.用于预防腹膜透析患者腹膜炎的抗菌药物。
Cochrane Database Syst Rev. 2017 Apr 8;4(4):CD004679. doi: 10.1002/14651858.CD004679.pub3.
3
Systematic review of the effectiveness of preventing and treating Staphylococcus aureus carriage in reducing peritoneal catheter-related infections.预防和治疗金黄色葡萄球菌定植在减少腹膜导管相关感染方面有效性的系统评价
Health Technol Assess. 2007 Jul;11(23):iii-iv, ix-x, 1-66. doi: 10.3310/hta11230.
4
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
5
Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials.预防腹膜透析腹膜炎的导管相关干预措施:随机对照试验的系统评价
J Am Soc Nephrol. 2004 Oct;15(10):2735-46. doi: 10.1097/01.ASN.0000141463.95561.79.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.预防性全身用抗真菌药物预防极低出生体重儿的死亡率和发病率。
Cochrane Database Syst Rev. 2007 Oct 17(4):CD003850. doi: 10.1002/14651858.CD003850.pub3.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

引用本文的文献

1
Fungal peritonitis in a patient on peritoneal dialysis caused by : A rare pathogen in human infection.腹膜透析患者发生真菌性腹膜炎,病因是:一种人类感染中的罕见病原体。
Med Mycol Case Rep. 2025 Mar 7;48:100699. doi: 10.1016/j.mmcr.2025.100699. eCollection 2025 Jun.
2
Serum Galactomannan: A Predictor of Poor Outcomes in Peritoneal Dialysis Patients With Fungal Peritonitis.血清半乳甘露聚糖:真菌性腹膜炎腹膜透析患者预后不良的预测指标。
Kidney Int Rep. 2023 Nov 11;9(2):287-295. doi: 10.1016/j.ekir.2023.11.002. eCollection 2024 Feb.
3
Phenotypic and genotypic characterization of virulence markers and antifungal susceptibility of oral Candida species from diabetic and non-diabetic hemodialysis patients.
从糖尿病和非糖尿病血液透析患者的口腔念珠菌中进行表型和基因型毒力标志物特征分析及抗真菌药敏试验。
BMC Oral Health. 2023 May 4;23(1):261. doi: 10.1186/s12903-023-02970-8.
4
Fungal Peritonitis Associated With Peritoneal Dialysis Due to Non-Albicans Candida: A Case Series.非白色念珠菌所致腹膜透析相关真菌性腹膜炎:病例系列
Cureus. 2022 Dec 18;14(12):e32658. doi: 10.7759/cureus.32658. eCollection 2022 Dec.
5
Peritoneal dialysis-associated peritonitis caused by : A case report and review of literature.腹膜透析相关性腹膜炎病因:一例病例报告及文献综述
Med Mycol Case Rep. 2022 Jan 28;35:43-47. doi: 10.1016/j.mmcr.2021.12.006. eCollection 2022 Mar.
6
[Risk factors of occurrence and treatment failure of peritoneal dialysis-associated polymicrobial peritonitis: a multicenter retrospective study].腹膜透析相关性多微生物腹膜炎发生及治疗失败的危险因素:一项多中心回顾性研究
Nan Fang Yi Ke Da Xue Xue Bao. 2021 Aug 31;41(9):1350-1357. doi: 10.12122/j.issn.1673-4254.2021.09.09.
7
Continuous ambulatory peritoneal dialysis-associated Histoplasma capsulatum peritonitis: a case report and literature review.与持续性不卧床腹膜透析相关的荚膜组织胞浆菌腹膜炎:病例报告及文献复习。
BMC Infect Dis. 2020 Sep 29;20(1):717. doi: 10.1186/s12879-020-05441-5.
8
Peritonitis by in a pediatric patient.一名儿科患者发生的腹膜炎。 (注:原文“by in”表述有误,推测正确内容可能是“by...”或“in a...”之类,这里按“in a”进行了翻译调整)
Med Mycol Case Rep. 2019 Feb 15;24:18-22. doi: 10.1016/j.mmcr.2019.02.001. eCollection 2019 Jun.
9
Fungal peritonitis in peritoneal dialysis: 5-year review from a North China center.华北中心 5 年回顾:腹膜透析相关性真菌性腹膜炎。
Infection. 2019 Feb;47(1):35-43. doi: 10.1007/s15010-018-1204-7. Epub 2018 Aug 25.
10
Peritoneal dialysis associated infections: An update on diagnosis and management.腹膜透析相关感染:诊断与管理的最新进展
World J Nephrol. 2012 Aug 6;1(4):106-22. doi: 10.5527/wjn.v1.i4.106.